Christopher Ma1, Matthew K Smith2, Leonardo Guizzetti3, Remo Panaccione4, Gilaad G Kaplan5, Kerri L Novak4, Cathy Lu4, Reena Khanna6, Brian G Feagan7, Siddharth Singh8, Vipul Jairath7, Ashwin N Ananthakrishnan9. 1. Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Robarts Clinical Trials, Inc, London, Ontario, Canada. Electronic address: christopher.ma@ucalgary.ca. 2. Department of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada. 3. Robarts Clinical Trials, Inc, London, Ontario, Canada. 4. Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada. 5. Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. 6. Division of Gastroenterology, Western University, London, Ontario, Canada. 7. Robarts Clinical Trials, Inc, London, Ontario, Canada; Division of Gastroenterology, Western University, London, Ontario, Canada; Department of Biostatistics and Epidemiology, Western University, London, Ontario, Canada. 8. Division of Gastroenterology, University of California San Diego, La Jolla, California. 9. Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts.
Abstract
BACKGROUND & AIMS: Patients with inflammatory bowel diseases (IBDs) require repeated health care encounters, although the focus of care differs when patients are seen in ambulatory, emergency department (ED), or inpatient settings. We examined contemporary trends and disparities in IBD-related health care visits. METHODS: We used data from the National Ambulatory Medical Care Survey, the Nationwide Emergency Department Sample, and the National Inpatient Sample to estimate the total number of annual IBD-related visits from 2005 through 2016. We performed logistic regression analyses to test temporal linear trends. Slope and differences in distributions of patient demographics were compared across time and treatment settings. RESULTS: From 2005 through 2016, approximately 2.2 million IBD-related ambulatory visits (95 CI, 1.9-2.5) occurred annually on average, increasing by 70.3% from the time period of 2005 to 2007 through the time period of 2008 to 2010, and decreasing by 19.8% from the time period of 2011 to 2013 through the time period of 2014 to 2016. An average of 115,934 IBD-related ED visits (95% CI, 113,758-118,111) and 89,111 IBD-related hospital discharges (95% CI, 87,416-90,807) occurred annually. Significant increases in the rate of IBD-related ED visits (3.2 visits/10,000 encounters; P < .0001) and hospital discharges (6.0 discharges/10,000 encounters; P < .0001) were observed from 2005 through 2016. The proportion of patients paying with private insurance decreased from 2005 through 2016, among all care settings. A greater proportion of young patients, patients with Crohn's disease, non-white patients, and patients with Medicare or Medicaid used hospital-based vs ambulatory services. CONCLUSIONS: In an analysis of data from 3 large databases, we found that although IBD-related ambulatory visits stabilized to decreased from 2005 through 2016, rates of ED use and admission to the hospital have continued to increase with changes in patient demographics, over time and among care settings.
BACKGROUND & AIMS:Patients with inflammatory bowel diseases (IBDs) require repeated health care encounters, although the focus of care differs when patients are seen in ambulatory, emergency department (ED), or inpatient settings. We examined contemporary trends and disparities in IBD-related health care visits. METHODS: We used data from the National Ambulatory Medical Care Survey, the Nationwide Emergency Department Sample, and the National Inpatient Sample to estimate the total number of annual IBD-related visits from 2005 through 2016. We performed logistic regression analyses to test temporal linear trends. Slope and differences in distributions of patient demographics were compared across time and treatment settings. RESULTS: From 2005 through 2016, approximately 2.2 million IBD-related ambulatory visits (95 CI, 1.9-2.5) occurred annually on average, increasing by 70.3% from the time period of 2005 to 2007 through the time period of 2008 to 2010, and decreasing by 19.8% from the time period of 2011 to 2013 through the time period of 2014 to 2016. An average of 115,934 IBD-related ED visits (95% CI, 113,758-118,111) and 89,111 IBD-related hospital discharges (95% CI, 87,416-90,807) occurred annually. Significant increases in the rate of IBD-related ED visits (3.2 visits/10,000 encounters; P < .0001) and hospital discharges (6.0 discharges/10,000 encounters; P < .0001) were observed from 2005 through 2016. The proportion of patients paying with private insurance decreased from 2005 through 2016, among all care settings. A greater proportion of young patients, patients with Crohn's disease, non-white patients, and patients with Medicare or Medicaid used hospital-based vs ambulatory services. CONCLUSIONS: In an analysis of data from 3 large databases, we found that although IBD-related ambulatory visits stabilized to decreased from 2005 through 2016, rates of ED use and admission to the hospital have continued to increase with changes in patient demographics, over time and among care settings.
Authors: Stephanie Coward; Fiona Clement; Eric I Benchimol; Charles N Bernstein; J Antonio Avina-Zubieta; Alain Bitton; Mathew W Carroll; Glen Hazlewood; Kevan Jacobson; Susan Jelinski; Rob Deardon; Jennifer L Jones; M Ellen Kuenzig; Desmond Leddin; Kerry A McBrien; Sanjay K Murthy; Geoffrey C Nguyen; Anthony R Otley; Remo Panaccione; Ali Rezaie; Greg Rosenfeld; Juan Nicolás Peña-Sánchez; Harminder Singh; Laura E Targownik; Gilaad G Kaplan Journal: Gastroenterology Date: 2019-01-10 Impact factor: 22.682
Authors: Teresa B Gibson; Eliza Ng; Ronald J Ozminkowski; Shaohung Wang; Wayne N Burton; Ron Z Goetzel; Ross Maclean Journal: J Occup Environ Med Date: 2008-11 Impact factor: 2.162
Authors: Christopher Ma; Gordon W Moran; Eric I Benchimol; Laura E Targownik; Steven J Heitman; James N Hubbard; Cynthia H Seow; Kerri L Novak; Subrata Ghosh; Remo Panaccione; Gilaad G Kaplan Journal: Am J Gastroenterol Date: 2017-10-31 Impact factor: 10.864
Authors: Sanjay K Murthy; Jahanara Begum; Eric I Benchimol; Charles N Bernstein; Gilaad G Kaplan; Jeffrey D McCurdy; Harminder Singh; Laura Targownik; Monica Taljaard Journal: Gut Date: 2019-06-12 Impact factor: 23.059
Authors: Parambir S Dulai; Victoria Rai; Laura E Raffals; Dana Lukin; David Hudesman; Gursimran S Kochhar; Oriana M Damas; Jenny S Sauk; Alexander N Levy; M Anthony Sofia; Anne Tuskey; Parakkal Deepak; Andres J Yarur; Anita Afzali; Ashwin N Ananthakrishnan; Raymond K Cross; Stephen B Hanauer; Corey A Siegel Journal: Am J Gastroenterol Date: 2022-04-13 Impact factor: 12.045
Authors: Siddharth Singh; Deborah Proctor; Frank I Scott; Yngve Falck-Ytter; Joseph D Feuerstein Journal: Gastroenterology Date: 2021-06 Impact factor: 33.883
Authors: Vipul Yadav; Yang Mai; Laura E McCoubrey; Yasufumi Wada; Motoyasu Tomioka; Satofumi Kawata; Shrikant Charde; Abdul W Basit Journal: Biomedicines Date: 2021-05-20
Authors: Aman K Dheri; M Ellen Kuenzig; David R Mack; Sanjay K Murthy; Gilaad G Kaplan; Jessy Donelle; Glenys Smith; Eric I Benchimol Journal: J Crohns Colitis Date: 2021-12-18 Impact factor: 9.071